| Literature DB >> 25068645 |
X P Lin1, L Feng2, C G Xie3, D B Chen3, Z Pei3, X L Liang3, Q Y Xie4, X H Li5, S Y Pan6.
Abstract
Machado-Joseph disease (MJD) is caused by a (CAG)n trinucleotide repeat expansion that is translated into an abnormally long polyglutamine tract. This disease is considered the most common form of spinocerebellar ataxia (SCA). In the present study, we developed stable inducible cell lines (PC12Tet-On-Ataxin-3-Q28/84) expressing ataxin-3 with either normal or abnormal CAG repeats under doxycycline control. The expression of acetyl histone H3 and the induction of c-Fos in response to cAMP were strongly suppressed in cells expressing the protein with the expanded polyglutamine tract. Treatment with valproic acid, a histone deacetylase inhibitor (HDACi), attenuated mutant ataxin-3-induced cell toxicity and suppression of acetyl histone H3, phosphorylated cAMP-responsive element binding protein (p-CREB) as well as c-Fos expression. These results indicate that VPA can stimulate the up-regulation of gene transcription through hyperacetylation. Thus, VPA might have a therapeutic effect on MJD.Entities:
Keywords: CREB; HDAC inhibitor; MJD; Valproic acid
Mesh：
Substances：
Year: 2014 PMID： 25068645 DOI： 10.1016/j.ijdevneu.2014.07.004
Source DB: PubMed Journal: Int J Dev Neurosci ISSN： 0736-5748 Impact factor: 2.457